These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 17255272)
1. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272 [TBL] [Abstract][Full Text] [Related]
2. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237 [TBL] [Abstract][Full Text] [Related]
3. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. Wu D; Ding Y; Wang S; Zhang Q; Liu L J Pathol; 2008 Oct; 216(2):167-75. PubMed ID: 18680137 [TBL] [Abstract][Full Text] [Related]
5. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma. Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma. Cao JY; Liu L; Chen SP; Zhang X; Mi YJ; Liu ZG; Li MZ; Zhang H; Qian CN; Shao JY; Fu LW; Xia YF; Zeng MS Mol Cancer; 2010 Sep; 9():237. PubMed ID: 20828406 [TBL] [Abstract][Full Text] [Related]
7. Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma. Xie LQ; Bian LJ; Li Z; Li Y; Liang YJ Oncol Rep; 2010 Jan; 23(1):141-50. PubMed ID: 19956874 [TBL] [Abstract][Full Text] [Related]
8. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412 [TBL] [Abstract][Full Text] [Related]
9. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival. Vera-Sempere FJ; Burgos JS; Botella MS; Morera C Histol Histopathol; 1997 Jan; 12(1):9-18. PubMed ID: 9046038 [TBL] [Abstract][Full Text] [Related]
11. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218 [TBL] [Abstract][Full Text] [Related]
13. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Li W; Yu CP; Xia JT; Zhang L; Weng GX; Zheng HQ; Kong QL; Hu LJ; Zeng MS; Zeng YX; Li M; Li J; Song LB Clin Cancer Res; 2009 Feb; 15(4):1393-9. PubMed ID: 19228740 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977 [TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of Centromere protein H expression in esophageal carcinoma. Guo XZ; Zhang G; Wang JY; Liu WL; Wang F; Dong JQ; Xu LH; Cao JY; Song LB; Zeng MS BMC Cancer; 2008 Aug; 8():233. PubMed ID: 18700042 [TBL] [Abstract][Full Text] [Related]
17. MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Tse KP; Tsang NM; Chen KD; Li HP; Liang Y; Hsueh C; Chang KP; Yu JS; Hao SP; Hsieh LL; Chang YS Clin Cancer Res; 2007 Nov; 13(21):6320-6. PubMed ID: 17975143 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995 [TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of centromere protein A in human lung adenocarcinoma. Wu Q; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH Lung Cancer; 2012 Aug; 77(2):407-14. PubMed ID: 22542705 [TBL] [Abstract][Full Text] [Related]
20. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Zhou J; Wang S; Lu J; Li J; Ding Y Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]